Literature DB >> 16314221

Neuroprotection and regeneration in glaucoma.

Leonard A Levin1.   

Abstract

Glaucoma is the most common optic neuropathy. Preventing visual loss is being studied with neuroprotective therapies. Visual restoration requires a restoration of retinal ganglion cells and their axons, ie, neurorepair and neuroregeneration. This review surveys recent developments in neuroprotection and regeneration from the standpoint of eventual applicability to treatment of patients who have glaucoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314221     DOI: 10.1016/j.ohc.2005.07.001

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  7 in total

1.  Histological, morphometric, protein and gene expression analyses of rat retinas with ischaemia-reperfusion injury model treated with sildenafil citrate.

Authors:  Diogo S Zanoni; Germana A Da Silva; Raaya Ezra-Elia; Márcio Carvalho; Juliany G Quitzan; Ron Ofri; José L Laus; Renee Laufer-Amorim
Journal:  Int J Exp Pathol       Date:  2017-06       Impact factor: 1.925

2.  Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma.

Authors:  Jian-He Xiao; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

3.  A modified chronic ocular hypertension rat model for retinal ganglion cell neuroprotection.

Authors:  Lichun Zhong
Journal:  Front Med       Date:  2013-06-06       Impact factor: 4.592

4.  Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.

Authors:  Jessica A Cooke; Jason S Meyer
Journal:  Curr Ophthalmol Rep       Date:  2015-08-07

Review 5.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

6.  Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats.

Authors:  T Jehle; D Ehlken; K Wingert; T J Feuerstein; M Bach; W A Lagrèze
Journal:  Doc Ophthalmol       Date:  2009-01-04       Impact factor: 2.379

7.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.